EX-FILING FEES 4 d296560dexfilingfees.htm EX-FILING FEES EX-FILING FEES

Exhibit 107

Calculation of Filing Fee Tables

Post-Effective Amendment to Form S-3

(Form Type)

Fulcrum Therapeutics, Inc.

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered and Carry Forward Securities

CALCULATION OF REGISTRATION FEE

 

     Security
Type		   Security
Class Title		   Fee
Calculation
or Carry
Forward
Rule		     Amount
Registered		     Proposed
Maximum
Offering
Price
Per Unit		  
Maximum
Aggregate
Offering Price		     Fee Rate    

Amount of
Registration

Fee

     Carry
Forward
Form
Type		     Carry
Forward
File
Number		     Carry
Forward
Initial
Effective
Date		      Filing Fee
Previously
Paid in
Connection
with
Unsold
Securities
to be
Carried
Forward		  
Newly Registered Securities

 

    Primary Offering of Securities

 

                                                             
Fees to be Paid   Debt   Debt Securities     457(r)       (1)     (2)     (3)               (4)                                   
Fees to be Paid   Equity   Common Stock, par value $0.001 per share     457(r)       (1)     (2)     (3)               (4)                                   
Fees to be Paid   Equity   Preferred Stock, par value $0.001 per share     457(r)       (1)     (2)     (3)               (4)                                   
Fees to be Paid   Other   Depositary Shares(5)     457(r)       (1)     (2)     (3)               (4)                                   
Fees to be Paid   Other   Units(6)     457(r)       (1)     (2)     (3)               (4)                                   
Fees to be Paid   Other   Warrants     457(r)       (1)     (2)     (3)               (4)                                   
Fees to be Paid  

Unallocated

(Universal) Shelf

   —     457(o)       $250,000,000 (7)    (2)     $250,000,000(7)       0.0000927       (4)(7)                                   
Fees to be Paid   Total Registration Fee:

 

     $100,000,000     (2)     $100,000,000       0.0000927       $9,270(4)                                   
Carry Forward Securities  
Carry Forward Securities   Equity   Common Stock, par value $0.001 per share     457(b)     $ 80,913,050(7)     N/A     $80,913,050       0.0000927       $7,500.64(7)       S-3ASR       333-260754      
 November 4,
2021		  
 		      $7,500.64  
Carry Forward Securities   Equity   Common Stock, par value $0.001 per share     457(b)     $ 69,086,950(7)     N/A     $69,086,950       0.0001298       $8,967.49(7)       S-3       333-244136      
 August 11,
2020		  
 		      $8,967.49  
Total Offering Amounts

 

         $250,000,000(7)       0.0000927       $23,175(7)                                   
Total Fees Previously Paid

 

                         $16,468.28(7)                                   
Total Fee Offsets

 

                         —                                   
Net Fee Due

 

                         $9,270                                   
(1)

The amount to be registered consists of up to $250,000,000 of an indeterminate amount of debt securities, common stock, preferred stock, depositary shares, warrants and/or units. There is also being registered hereunder such currently indeterminate number of (i) shares of common stock or other securities of the registrant as may be issued upon conversion of, or in exchange for, convertible or exchangeable debt securities and/or preferred stock registered hereby, or (ii) shares of preferred stock, common stock, debt securities or units as may be issued upon exercise of warrants registered hereby, as the case may be, or in each case, pursuant to the antidilution provisions of such securities. Any securities registered hereunder may be sold separately or as units with the other securities registered hereunder.

(2)

The proposed maximum aggregate offering price per unit will be determined from time to time by the registrant in connection with the issuance by the registrant of the securities registered hereunder and is not specified as to each class of security pursuant to General Instruction II.D. of Form S-3 under the Securities Act.

(3)

Estimated solely for purposes of computing the registration fee. No separate consideration will be received for (i) common stock or other securities of the registrant that may be issued upon conversion of, or in exchange for, convertible or exchangeable debt securities and/or preferred stock registered hereby, or (ii) preferred stock, common stock, debt securities or units that may be issued upon exercise of warrants registered hereby, as the case may be.

(4)

The registration fee has been calculated in accordance with Rule 457(o) under the Securities Act.

(5)

Each depositary share will be issued under a deposit agreement, will represent an interest in a fractional share or multiple shares of preferred stock and will be evidenced by a depositary receipt.

(6)

Units may be issued under a unit agreement and will represent an interest in one or more securities registered hereby including debt securities, shares of common stock, shares of preferred stock, depositary shares or warrants, in any combination, which may or may not be separable from one another.

(7)

The registrant previously paid a filing fee for a primary offering of $150,000,000 of the registrant’s shares of common stock (consisting of $80,913,050 newly registered securities for which it paid $7,500.64 of fees and $69,086,950 of unsold securities carried forward from a prior registration statement on Form S-3 for which it previously paid $8,967.49 of fees (calculated at the filing fee rate in effect at the time of the filing of such prior registration statement)) pursuant to a prospectus filed by the registrant on November 4, 2021. All of such $150,000,000 shares of common stock remain unsold, and is being carried forward on this registration statement, and the registrant is registering an additional $100,000,000 of securities. Accordingly, the filing fee for such newly registered securities is $9,270 and is being paid upon filing of this Amendment No. 1.

 

Table 2: Fee Offset Claims and Sources

 

      Registrant
or Filer
Name		    Form
or
Filing
Type		    File
Number		    Initial
Filing Date		    Filing Date    Fee
Offset
Claimed		    Security
Type
Associated
with Fee
Offset
Claimed		    Security
Title
Associated
with Fee
Offset
Claimed		    Unsold
Securities
Associated
with Fee
Offset
Claimed		    Unsold
Aggregate
Offering
Amount
Associated
with Fee
Offset
Claimed		    Fee
Paid
with
Fee
Offset
Source
Rule 457(b) and 0-11(a)(2)
Fee Offset Claims                                                       
Fee Offset Sources   

Fulcrum

Therapeutics,

Inc.

    S-3    333-244136    August 11, 2020    August 11, 2020    $8,967.49    Equity    Common Stock, par value $0.001 per share    N/A    $69,086,950    $32,450
Fee Offset Sources   

Fulcrum

Therapeutics,

Inc.

    S-3ASR    333-260754    November 4, 2021    November 4, 2021    $7,500.64    Equity    Common Stock, par value $0.001 per share    N/A    $80,913,050    $7,500.64
Rule 457(p)
Fee Offset    —    —    —    —    —    —    —    —    —    —    —
Claims    —    —    —    —    —    —    —    —    —    —    —